Viewing Study NCT03376659


Ignite Creation Date: 2025-12-24 @ 2:41 PM
Ignite Modification Date: 2026-02-02 @ 5:26 PM
Study NCT ID: NCT03376659
Status: TERMINATED
Last Update Posted: 2024-02-05
First Post: 2017-11-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma
Sponsor: Georgetown University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-08-08
Start Date Type: ACTUAL
Primary Completion Date: 2021-08-30
Primary Completion Date Type: ACTUAL
Completion Date: 2023-08-01
Completion Date Type: ACTUAL
First Submit Date: 2017-11-20
First Submit QC Date: None
Study First Post Date: 2017-12-18
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-10-14
Results First Submit QC Date: None
Results First Post Date: 2023-01-10
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-02-01
Last Update Post Date: 2024-02-05
Last Update Post Date Type: ACTUAL